2. Academic Validation
  3. Columbamine suppresses the proliferation and malignization of colon cancer cells via abolishing Wnt/β-catenin signaling pathway

Columbamine suppresses the proliferation and malignization of colon cancer cells via abolishing Wnt/β-catenin signaling pathway

  • Cancer Manag Res. 2019 Sep 23:11:8635-8645. doi: 10.2147/CMAR.S209861.
Changjiang Lei # 1,  Yao Yao # 2,  Bin Shen # 3,  Junru Liu # 2,  Qingyun Pan # 4,  Ning Liu 1,  Lei Li 1,  Jianbin Huang 1,  Zhixiong Long 2,  Liwei Shao 1
Affiliations

Affiliations

  • 1 Department of General Surgery, Fifth Hospital in Wuhan, Wuhan, Hubei 430050, People's Republic of China.
  • 2 Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, People's Republic of China.
  • 3 Department of Hepatobiliary Surgery, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001, Zhejiang, People's Republic of China.
  • 4 Department of Blood Endocrinology, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, People's Republic of China.
  • # Contributed equally.
PMID: 31572013 DOI: 10.2147/CMAR.S209861
Abstract

Background: Colon Cancer is one of the most common malignancies worldwide. Because of the side effects and defects in tolerance of chemotherapy, it is necessary to discover new drugs for colon Cancer treatment. Columbamine has been identified as an effective anti-osteosarcoma compound with only minor side effects. In this study, we analyzed the Anticancer effect of columbamine on colon Cancer.

Methods: Human colon Cancer cell lines were treatment with columbamine. MTT assay, colony formation assay, Apoptosis detection and tumorigenicity assay were performed to detect the protective effect of columbamine on colon Cancer development. Western blot assay and luciferase reporter assay were conducted to investigate the potential mechanism of the columbamine treatment.

Results: Columbamine significantly inhibited the proliferation, migration, invasion process of colon Cancer cells, and dramatically promoted the Apoptosis rate of colon Cancer cells to further suppress the development of colon Cancer to tumor. Both the signaling transducing and key factors expression of Wnt/β-catenin signaling pathway were obviously repressed by columbamine treatment in a dose-dependent manner.

Conclusion: The present study indicated that columbamine exerts its anti-tumor effect in colon Cancer cells through abolishing Wnt/β-catenin signaling pathway. Columbamine may be a new therapy compound for colon Cancer.

Keywords

HCT116; LoVo; apoptosis; cells growth; colon cancer.

Figures
Products